CNT and Graphene-Based Transistor Biosensors for Cancer Detection: A Review

Abstract

An essential aspect of successful cancer diagnosis is the identification of malignant tumors during the early stages of development, as this can significantly diminish patient mortality rates and increase their chances of survival. This task is facilitated by cancer biomarkers, which play a crucial role in determining the stage of cancer cells, monitoring their growth, and evaluating the success of treatment. However, conventional cancer detection methods involve several intricate steps, such as time-consuming nucleic acid amplification, target detection, and a complex treatment process that may not be appropriate for rapid screening. Biosensors are emerging as promising diagnostic tools for detecting cancer, and carbon nanotube (CNT)- and graphene-based transistor biosensors have shown great potential due to their unique electrical and mechanical properties. These biosensors have high sensitivity and selectivity, allowing for the rapid detection of cancer biomarkers at low concentrations. This review article discusses recent advances in the development of CNT- and graphene-based transistor biosensors for cancer detection.

Point-of-care devices engaging green graphene: an eco-conscious and sustainable paradigm

“…The landscape of medical diagnostics has been reshaped by these innovative instruments through the offering of rapid and convenient solutions right at the patient's side or in close proximity to their care environment. Not only in their convenience but also in their capacity to play a pivotal role in the early detection of diseases, 37 continuous monitoring of health parameters, and the timely initiation of treatment interventions, lies the significance of POC devices. This, in turn, is associated with a profound impact on patient outcomes, promoting faster recovery, more effective management of pandemic conditions, 38 and even the potential for saving lives.…”

Probe-screened carbon nanotube field-effect transistor biosensor to enhance breast cancer-related gene assay

“…[5] With an ultra-thin body, every atom of CNTs is exposed to the environment, which makes CNTs are extremely sensitive to specific biological molecules or receptor changes on the surface. According to the published reports, [6] CNT-FET biosensors have been widely studied in early cancer detection. When the biological species (nucleic acids, proteins, neurotransmitters) are captured on the channel surface, the electrical conductivity of the CNTs changes.…”